These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8730507)
1. A pilot study on the effectiveness of cyclosporine in type II mixed cryoglobulinemia. Ballarè M; Bobbio F; Poggi S; Bordin G; Bertoncelli MC; Catania E; Monteverde A Clin Exp Rheumatol; 1995; 13 Suppl 13():S201-3. PubMed ID: 8730507 [TBL] [Abstract][Full Text] [Related]
2. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. La Civita L; Zignego AL; Lombardini F; Monti M; Longombardo G; Pasero G; Ferri C J Rheumatol; 1996 Sep; 23(9):1641-3. PubMed ID: 8877939 [TBL] [Abstract][Full Text] [Related]
3. Interferon in the treatment of mixed cryoglobulinemia. Migliaresi S; Tirri G Clin Exp Rheumatol; 1995; 13 Suppl 13():S175-80. PubMed ID: 8730502 [TBL] [Abstract][Full Text] [Related]
5. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712 [TBL] [Abstract][Full Text] [Related]
6. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. Mazzaro C; Zorat F; Caizzi M; Donada C; Di Gennaro G; Maso LD; Carniello G; Virgolini L; Tirelli U; Pozzato G J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon. Mazzaro C; Colle R; Baracetti S; Nascimben F; Zorat F; Pozzato G Clin Exp Rheumatol; 2002; 20(1):27-34. PubMed ID: 11892704 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis. Lo KY; Chen CY; Lee CS Ren Fail; 2009; 31(2):149-52. PubMed ID: 19212913 [TBL] [Abstract][Full Text] [Related]
9. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189 [TBL] [Abstract][Full Text] [Related]
10. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study. Caniatti LM; Tugnoli V; Eleopra R; Tralli G; Bassi R; De Grandis D J Peripher Nerv Syst; 1996; 1(2):131-8. PubMed ID: 10975721 [TBL] [Abstract][Full Text] [Related]
11. Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia. Mazzaro C; Lacchin T; Moretti M; Tulissi P; Manazzone O; Colle R; Pozzato G Clin Exp Rheumatol; 1995; 13 Suppl 13():S181-5. PubMed ID: 8730503 [TBL] [Abstract][Full Text] [Related]
12. Failure of cyclosporin therapy in type II mixed cryoglobulinemia associated with hepatitis C virus infection. Horsmans Y; Tennstedt D; Cornu C; Geubel AP Clin Exp Rheumatol; 1998; 16(4):514-5. PubMed ID: 9706447 [No Abstract] [Full Text] [Related]
13. Ribavirin in hepatitis C related cryoglobulinemia. Durand JM; Cacoub P; Lunel-Fabiani F; Cosserat J; Cretel E; Kaplanski G; Frances C; Bletry O; Soubeyrand J; Godeau P J Rheumatol; 1998 Jun; 25(6):1115-7. PubMed ID: 9632073 [TBL] [Abstract][Full Text] [Related]
14. Colchicine in the treatment of mixed cryoglobulinemia. Monti G; Saccardo F; Rinaldi G; Petrozzino MR; Gomitoni A; Invernizzi F Clin Exp Rheumatol; 1995; 13 Suppl 13():S197-9. PubMed ID: 8730506 [TBL] [Abstract][Full Text] [Related]
15. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235 [TBL] [Abstract][Full Text] [Related]
16. Relationship between rheumatoid factor and the immune response against hepatitis C virus in essential mixed cryoglobulinemia. Pietrogrande M; Corona M; Milani S; Rosti A; Ramella M; Tordato G Clin Exp Rheumatol; 1995; 13 Suppl 13():S109-13. PubMed ID: 8730489 [TBL] [Abstract][Full Text] [Related]
17. HCV genotypes in bone marrow and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia. Zehender G; de Maddalena C; Monti G; Ballare M; Saccardo F; Piconi S; Invernizzi F; Monteverde A; Galli M Clin Exp Rheumatol; 1995; 13 Suppl 13():S87-90. PubMed ID: 8730484 [TBL] [Abstract][Full Text] [Related]
18. Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b. De Blasi T; Aguilar Marucco D; Cariti G; Maiello A; De Rosa FG; Di Perri G Infection; 2008 Jun; 36(3):285-7. PubMed ID: 17962905 [TBL] [Abstract][Full Text] [Related]
20. Purpura with cold urticaria in a patient with hepatitis C virus infection-associated mixed cryoglobulinemia type III: successful treatment with interferon-beta. Ito A; Kazama T; Ito K; Ito M J Dermatol; 2003 Apr; 30(4):321-5. PubMed ID: 12707469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]